Obstructive jaundice secondary to Hodgkin's disease

American Journal of Gastroenterology

Volumn 92, Issue 3, 1997, Pages 526-527

  Abe, Hideki ^a   Kubota, Keiichi ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE; CYCLOPHOSPHAMIDE; MERCAPTOPURINE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; COMMON BILE DUCT OBSTRUCTION; HODGKIN DISEASE; HUMAN; LYMPH NODE METASTASIS; MALE; OBSTRUCTIVE JAUNDICE; PANCREATICODUODENECTOMY; PRIORITY JOURNAL;

ADULT; CHOLESTASIS; COMMON BILE DUCT NEOPLASMS; HODGKIN DISEASE; HUMANS; MALE;

EID: 0031027769     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Boddie JAW, Eisenberg BL, Mullins JD, et al. The diagnosis and treatment of obstructive jaundice secondary to malignant lymphoma: A problem in multidisciplinary management. J Surg Oncol 1980;14:111-23.
2. Pariente D, Cornud F, Grenier P, et al. Atteinte de la voie biliaire principle dans la maladie de Hodgkin: A propos de trois cas. Sem Hop 1981;57:2027-30.
3. Santoro A, Bonfante V, Bonadonna G. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med 1982; 96:139-43.
4. Harker WG, Kushlan P, Rosenberg SA. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. Ann Intern Med 1984;101:440-6.
5. Uematsu M, Tarbell NJ, Silver B, et al. Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin's disease in relapse after initial combination chemotherapy. Cancer 1993;72:207-12.